SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-006291
Filing Date
2024-01-25
Accepted
2024-01-25 09:05:42
Documents
5
Period of Report
2024-01-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea192120-6k_scisparc.htm 6-K 19340
2 FORM OF PROMISSORY NOTE ea192120ex4-1_scisparc.htm EX-4.1 71725
3 STANDBY EQUITY PURCHASE AGREEMENT, DATED JANUARY 21, 2024 ea192120ex10-1_scisparc.htm EX-10.1 260979
4 PRESS RELEASE DATED JANUARY 24, 2024 ea192120ex99-1_scisparc.htm EX-99.1 7587
5 GRAPHIC ex99-1_001.jpg GRAPHIC 1857
  Complete submission text file 0001213900-24-006291.txt   363569
Mailing Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916
Business Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916 972-3-6103100
SciSparc Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 24558921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)